PRKCQ
PRKCQ (protein kinase C theta, PKCθ) is a calcium-independent, phospholipid- and diacylglycerol-dependent serine/threonine kinase of the protein kinase C family. It mediates T-cell receptor signalling and links the receptor complex to activation of transcription factors such as NF-κB and AP-1. Browse Assay Genie's current range of PRKCQ research reagents below, or read on for the biology behind the target.
PRKCQ is a calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine kinase with non-redundant functions in T-cell receptor (TCR) signalling. It supports T-cell activation, proliferation, differentiation and survival by driving transcription factors including NF-κB, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28 co-stimulated T-cells it is required for NF-κB and JUN activation, which are essential for IL2 production, and it contributes to calcium-dependent NFATC1 and NFATC2 transactivation by helping regulate inositol 1,4,5-trisphosphate generation and intracellular calcium mobilisation.
In the canonical NF-κB pathway, PRKCQ phosphorylates CARD11 on several serine residues. This brings CARD11 to lipid rafts and recruits the BCL10-MALT1 complex, which activates the IKK complex and leads to nuclear translocation of NFKB1. For JUN activation it phosphorylates STK39/SPAK. It also phosphorylates CBLB after CD28 costimulation, promoting CBLB degradation, and phosphorylates BAD to protect T-cells from apoptosis. During differentiation it is important for Th2 development and is necessary for activation of IL17-producing Th17 cells. In platelets it acts downstream of ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4. Other substrates include IRS1, MSN, PDPK1, CCDC88A/GIV and LRRK1.
The PRKCQ gene encodes a member of the AGC Ser/Thr protein kinase family, PKC subfamily, listed by HGNC among the C2 domain containing protein kinases. PKC family members also act as major receptors for phorbol esters, a class of tumour promoters, and each member has a specific expression profile and a distinct role. The protein was previously named protein kinase C, theta, and the mouse and rat orthologues are both Prkcq.
PRKCQ links the TCR signalling complex to NF-κB and AP-1 activation, making it a central node for studying T-cell activation.
The kinase contributes to Th2 development and is necessary for activation of IL17-producing Th17 cells in autoimmune and inflammatory settings.
Phosphorylation of CARD11 by PRKCQ recruits the BCL10-MALT1 complex and IKK, a route used to dissect canonical NF-κB activation.
PRKCQ acts downstream of platelet receptors and may mediate free fatty acid effects on insulin signalling through IRS1 phosphorylation.
PRKCQ is a serine/threonine kinase required for T-cell activation. After TCR and CD28 stimulation it activates NF-κB, JUN and NFAT transcription factors, supports IL2 production, and protects T-cells from apoptosis. It also acts in platelet signalling and phosphorylates substrates such as IRS1, PDPK1 and LRRK1.
PRKCQ is the HGNC symbol for protein kinase C theta, also written PKCθ. The previous gene name was protein kinase C, theta, and UniProt lists the protein as Protein kinase C theta type. Searches for the PRKCQ gene or PKCθ protein therefore refer to the same target.
Yes. Mouse and rat both have an orthologous gene named Prkcq. The human protein belongs to the PKC subfamily of the AGC kinase family. Check the datasheet of any product for its validated reactivity.
Other T-cell signalling proteins, NF-κB pathway components and PKC substrates with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q04759; product specifications from Assay Genie datasheets.